Tag: flibanserin
Addyi will be available in pharmacies on October 17th. The medical staff at Maze is all set to prescribe Addyi. We have passed the required exams and are certified prescribers. We are looking forward to offering this medication when we feel it is appropriate. It does seem this medication works best for women who had …
Continue Reading
Addyi, also known as Flibanserin, was recently approved by the FDA to treat low sexual desire in women. It is the first FDA approved medication for female sexual dysfunction. Addyi is a non-hormonal oral medication, with a seemingly low side effect profile, that in essence increases dopamine and noradrenaline while reducing serotonin in the brain …
Continue Reading
Here is the most significant thing to remember: sex is not just about what happens in the bedroom. My friend used to say that sex in a relationship is like the third leg of a stool. When it’s there, you don’t spend much time thinking about it, but when it’s gone the whole stool starts …
Continue Reading
Dr. Steven Snyder is a sex therapist as well as a medical doctor and wrote this excellent article about Flibanserin in Psychology Today, the so-called “pink viagra” for women. Professionals working in the field of female sexual health are anxiously awaiting the FDA’s decision on whether or not they will approve Flibanserin. Dr. Snyder ascertains …
Continue Reading
In a recent article in the New York Times entitled “Nothing Is Wrong With Your Sex Drive”, the author gave her opinion on the drug Flibanserin and her take on the history of low desire. My feeling is that this article may do many women a huge disservice. Unfortunately to assume that a woman’s low …
Continue Reading
I think this is a great article that talks about the medication Flibanserin and the controversy surrounding FDA approval for medications to treat female sexual dysfunction. Flibanserin is a non-hormonal oral medication, with a seemingly low side effect profile, that in essence increases dopamine and noradrenalin while reducing serotonin in the brain. According to some …
Continue ReadingThere has been a lot of media attention recently on the advent of 2 new drugs being tested for female sexual dysfunction: Lybrido and Lybridos. But those aren’t the only two drugs currently being tested. A drug called Flibanserin had been tested and went to the FDA a few years ago, testosterone supplements including Libigel …
Continue ReadingDaniel Bergner, is a contributor for the New York Times Magazine and author of several books including, The Other Side of Desire, which I loved. He just wrote a new book which was released last week, What do Women Want? Adventures in the Science of Female Desire. An excerpt from the book just appeared in …
Continue ReadingThere was a recent article in The New York Times Magazine that has generated some buzz in the field of human sexuality. The article was written by Daniel Bergner, a contributing writer for the NY Times magazine and is an adaptation from his new book, What Do Women Want?: Adventures in the Science of Female …
Continue ReadingThe latest public figure to make journalistic hay from the flibanserin controversy is Camille Paglia, whose editorial in The New York Times, ”No Sex Please, We’re Middle Class, “ seems to be getting some play on my twitter feed. It’s a fun read, but she throws a lot of things together that I’m not sure …
Continue ReadingFree 10 Minute Phone Consultation or For More Information
Call 914-328-3700 or complete the form below.
